Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID<sup>®</sup>) with Concomitant Medications in Real-World Clinical Settings
Background: This research article delves into the battle against the COVID-19 pandemic, focusing on the efficacy and, particularly, the safety of the combination of nirmatrelvir with ritonavir, which is found in the pharmaceutical product Paxlovid<sup>®</sup>. This study aims to analyze the potentia...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2024-11-01
|
| Serie: | Pathogens |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/2076-0817/13/12/1055 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|